Acta Medicinae Universitatis Scientiae et Technologiae Huazhong ›› 2026, Vol. 55 ›› Issue (5): 674-679.doi: 10.3870/j.issn.1672-0741.25.09.040

Previous Articles     Next Articles

The Molecular Mechanism of HMOX1 Regulating Ferroptosis in Endometriosis

Yin Xiangmei, Ma Xiangying, Su Xiaojuan et al   

  1. Department of Gynecology, Shijiazhuang People' s Hospital, Shijiazhuang 050000, China
  • Received:2025-09-22 Published:2026-10-30
  • Contact: △E-mail:13122777375@163.com

Abstract: Objective To investigate the molecular mechanism by which heme oxygenase-1 (HMOX1) regulates ferroptosis in endometriosis. Methods Human immortalized endometrial ectopic epithelial cells (hEM15A) were divided into blank control (Con) group, sh-NC group, and sh-HMOX1 group. The hEM15A cells in the sh-NC and sh-HMOX1 groups were transfected with negative control and interfering plasmids targeting HMOX1, respectively. Normal human endometrial stromal cells (hESCs) were divided into blank control (Con) group, FeSO4 group, FeSO4+sh-NC group, and FeSO4+sh-HMOX1 group. Cells in the FeSO4, FeSO4+sh-NC, and FeSO4+sh-HMOX1 groups were exposed to FeSO4 (100 μmol/L) solution for 24 hours. The hESCs in the FeSO4+sh-NC and FeSO4+sh-HMOX1 groups were transfected with negative control and interfering plasmids targeting HMOX1 prior to FeSO4 exposure. Cell viability was assessed using the Cell Counting Kit-8 (CCK-8) assay. Lipid peroxidation was measured by flow cytometry. Intracellular Fe²+ levels were analyzed by FeRhoNox-1 fluorescence staining. Cell migration ability was evaluated by Transwell assay, and pro-angiogenic activity was assessed by HUVECs tube formation assay. Expression of iron metabolism-related proteins was analyzed by Western blotting. Results Compared with hESCs, HMOX1 protein expression was upregulated in hEM15A cells. Compared with the sh-NC group, the sh-HMOX1 group exhibited decreased hEM15A cell viability, number of migrated cells, number of HUVEC tube formation,lipid ROS levels, Fe²+ levels, and ACSL4 protein expression (all P<0.05), while SLC7A11 and GPX4 protein expression was increased (both P<0.05). Compared with the Con group, the FeSO4 and FeSO4+sh-NC groups showed increased lipid ROS, Fe²+ levels, and HMOX1 and ACSL4 protein expression in hESCs (all P<0.05), whereas SLC7A11 and GPX4 protein expression was decreased (both P<0.05). Compared with the FeSO4+sh-NC group, the FeSO4+sh-HMOX1 group showed decreased lipid ROS, Fe²+ levels, and HMOX1 and ACSL4 protein expression in hESCs (all P<0.05), while SLC7A11 and GPX4 protein expression was increased (both P<0.05). Compared with the Con group, the FeSO4 and FeSO4+sh-NC groups exhibited increased numbers of migrated hESCs and HUVEC tube formation(all P<0.05). Compared with the FeSO4+sh-NC group, the FeSO4+sh-HMOX1 group showed decreased cell viability, number of migrated cells, and number of HUVEC tube formation in hESCs (all P<0.05). Conclusion Knockdown of HMOX1 may inhibit the progression of endometriosis by regulating ferroptosis, providing new evidence for HMOX1 as a potential therapeutic target for endometriosis.

Key words: endometriosis, ferroptosis, heme oxygenase-1, migration, angiogenesis

CLC Number: